There is evidence that the level of IL-18 in COVID-19 patients with MAS and ARDS is significantly higher than that in patients without MAS and ARDS, and high levels of IL-18 and IL-1Ra also seem to be related to the mortality of patients (181). The gene discussed is IL18; the disease is macrophage activation syndrome.